Skip to main content
Top
Published in: Calcified Tissue International 2/2017

01-08-2017 | Original Research

Serum Sclerostin Increases After Acute Physical Activity

Authors: Marie-Eva Pickering, Marie Simon, Elisabeth Sornay-Rendu, Karim Chikh, Marie-Christine Carlier, Anne-Lise Raby, Pawel Szulc, Cyrille B. Confavreux

Published in: Calcified Tissue International | Issue 2/2017

Login to get access

Abstract

Physical activity has a major impact on bone density and on osteoporosis prevention. Sclerostin is produced by osteocytes and inhibits bone formation. The impact of exercise on sclerostin secretion has not been studied so far. This pilot study aimed to explore circulating sclerostin levels immediately after acute exercise. Healthy young women practicing physical activity less than 120 min per week were enrolled. The exercise was a 45-min, low-speed, treadmill running test. Blood samples were taken at rest before exercise and within 5 min after the end of exercise. We assessed serum creatinine, 25-OH vitamin D, alkaline phosphatase, C-telopeptide of type I collagen, bone-specific alkaline phosphatase, and sclerostin. Sclerostin stability at rest was also validated over the same period of time among women fulfilling the same inclusion criteria. The study included 23 participants (mean ± SD age: 22.9 ± 1.5 years) for the exercise test and 9 participants for the resting test (26.1 ± 3.1 years). There was no difference in body mass index between the two groups. Sclerostin increased after exercise in comparison to baseline (mean ± SEM: 410 ± 27 vs. 290 ± 19 pg/mL; p < 0.001) corresponding to an increase of +44.3 ±5.5%. In the resting test, sclerostin remained stable (303 ± 20 vs. 294 ± 20 pg/mL, p = 0.76). There was a substantial increase in serum sclerostin in untrained healthy young women immediately after physical activity. These results suggest the existence of an acute release of systemic sclerostin in response to physical activity.
Literature
3.
go back to reference Wallace JD, Cuneo RC, Lundberg PA et al (2000) Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 85:124–133. doi:10.1210/jcem.85.1.6262 PubMed Wallace JD, Cuneo RC, Lundberg PA et al (2000) Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 85:124–133. doi:10.​1210/​jcem.​85.​1.​6262 PubMed
7.
go back to reference Ardawi M-SM, Al-Kadi HA, Rouzi AA, Qari MH (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res Off J Am Soc Bone Miner Res 26:2812–2822. doi:10.1002/jbmr.479 CrossRef Ardawi M-SM, Al-Kadi HA, Rouzi AA, Qari MH (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res Off J Am Soc Bone Miner Res 26:2812–2822. doi:10.​1002/​jbmr.​479 CrossRef
9.
go back to reference Acıbucu F, Dokmetas HS, Acıbucu DO, et al (2016) Effect of vitamin D treatment on serum sclerostin level. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. doi:10.1055/s-0035-1559790 Acıbucu F, Dokmetas HS, Acıbucu DO, et al (2016) Effect of vitamin D treatment on serum sclerostin level. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. doi:10.​1055/​s-0035-1559790
11.
go back to reference Gaudio A, Pennisi P, Bratengeier C et al (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248–2253. doi:10.1210/jc.2010-0067 CrossRefPubMed Gaudio A, Pennisi P, Bratengeier C et al (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248–2253. doi:10.​1210/​jc.​2010-0067 CrossRefPubMed
13.
go back to reference Morse LR, Sudhakar S, Danilack V et al (2012) Association between sclerostin and bone density in chronic spinal cord injury. J Bone Miner Res Off J Am Soc Bone Miner Res 27:352–359. doi:10.1002/jbmr.546 CrossRef Morse LR, Sudhakar S, Danilack V et al (2012) Association between sclerostin and bone density in chronic spinal cord injury. J Bone Miner Res Off J Am Soc Bone Miner Res 27:352–359. doi:10.​1002/​jbmr.​546 CrossRef
14.
go back to reference Ardawi M-SM, Rouzi AA, Qari MH (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 97:3691–3699. doi:10.1210/jc.2011-3361 CrossRefPubMed Ardawi M-SM, Rouzi AA, Qari MH (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 97:3691–3699. doi:10.​1210/​jc.​2011-3361 CrossRefPubMed
15.
go back to reference Amrein K, Amrein S, Drexler C et al (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 97:148–154. doi:10.1210/jc.2011-2152 CrossRefPubMed Amrein K, Amrein S, Drexler C et al (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 97:148–154. doi:10.​1210/​jc.​2011-2152 CrossRefPubMed
17.
go back to reference Scott JPR, Sale C, Greeves JP, et al (2011) The role of exercise intensity in the bone metabolic response to an acute bout of weight-bearing exercise. J Appl Physiol Bethesda Md 1985 110:423–432. doi:10.1152/japplphysiol.00764.2010 Scott JPR, Sale C, Greeves JP, et al (2011) The role of exercise intensity in the bone metabolic response to an acute bout of weight-bearing exercise. J Appl Physiol Bethesda Md 1985 110:423–432. doi:10.​1152/​japplphysiol.​00764.​2010
Metadata
Title
Serum Sclerostin Increases After Acute Physical Activity
Authors
Marie-Eva Pickering
Marie Simon
Elisabeth Sornay-Rendu
Karim Chikh
Marie-Christine Carlier
Anne-Lise Raby
Pawel Szulc
Cyrille B. Confavreux
Publication date
01-08-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 2/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0272-5

Other articles of this Issue 2/2017

Calcified Tissue International 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.